Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction

Pulmonary hypertension (PH) conveys a worse prognosis in heart failure (HF), in particular when right ventricular (RV) dysfunction ensues. Cardiovascular magnetic resonance (CMR) non-invasively estimates pulmonary vascular resistance (PVR), which has shown prognostic value in HF. Importantly, RV to...

Full description

Bibliographic Details
Authors: Trejo-Velasco, Blanca, Fabregat Andrés, Óscar, García-González, Pilar M., Perdomo-Londoño, Diana C., Cubillos-Arango, Andrés M., Ferrando-Beltrán, Mónica I., Belchi-Navarro, Joaquina, Pérez-Boscá, José L., Payá-Serrano, Rafael, Ridocci-Soriano, Francisco
Format: article
Publication Date:2020
Country:España
Institution:Universidad Católica de Valencia San Vicente Mártir
Repository:RIUCV. Repositorio de la Universidad Católica de Valencia San Vicente Mártir
Language:English
OAI Identifier:oai:riucv.ucv.es:20.500.12466/6959
Online Access:https://hdl.handle.net/20.500.12466/6959
Access Level:Open access
Keyword:HFrEF
Cardiac MRI
Right ventricle
Ventricular-arterial coupling
Prognosis
Pulmonary hypertension
32 Ciencias Médicas
Description
Summary:Pulmonary hypertension (PH) conveys a worse prognosis in heart failure (HF), in particular when right ventricular (RV) dysfunction ensues. Cardiovascular magnetic resonance (CMR) non-invasively estimates pulmonary vascular resistance (PVR), which has shown prognostic value in HF. Importantly, RV to pulmonary artery (PA) coupling is altered early in HF, before significant rise in PV resistance occurs. The aim of this study was to assess the prognostic value of mean velocity at the pulmonary artery (mvPA), a novel non-invasive parameter determined by CMR, in HF with reduced ejection fraction (HFrEF) with and without associated PH.

Similar Items